News Opinion Editor's Corner Olympic Hearts: Screening for CVD Among Team USA’s Athletes Michael O'Riordan July 31, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for July 2024 Shelley Wood July 31, 2024
News Daily News Industry Payments Made to Cardiology Fellows Prompt Bias Concerns Yael L. Maxwell July 16, 2024
News Daily News Women Appear to Quit Interventional Cardiology More Often Than Men Do Caitlin E. Cox July 16, 2024
News Daily News Going Global: Asia-Pacific Region Not Represented in Large Clinical Trials Todd Neale July 10, 2024
News Features Let’s Talk About Sex: How Best to Broach Post-MI Conversations Caitlin E. Cox June 14, 2024
News Daily News UK Physicians, Decrying Scope Creep, Ask Royal College President to Resign Caitlin E. Cox June 12, 2024
News Daily News Don’t Worry About Muscle Loss With GLP-1 Inhibitors, Viewpoint Asserts Yael L. Maxwell June 10, 2024
News Daily News What Makes a ‘Doctor’? UK Anesthetists Raising Funds for Legal Action Caitlin E. Cox June 07, 2024
Presentation NY Valves 2024 Post-Market Considerations: How Can We Ensure Rational Diffusion of TTVI, Optimal Training and Maintenance of Quality? Presenter: Susheel K. Kodali June 06, 2024
News Daily News Pollution Deserves More Attention in Cardiology—and More Action Yael L. Maxwell June 03, 2024
News Conference News HRS 2024 Goal of Arrhythmia Care in Athletes is a Return to Play: HRS Consensus Michael O'Riordan May 23, 2024
News Daily News New HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise Yael L. Maxwell May 08, 2024
News Opinion Fellow Talk Free Tuition Won’t Improve Diversity in Medical School Chris Sossou, MD April 16, 2024
News Conference News ACC 2024 Telemedicine Strategy After MI Scores a Win in TELE-ACS Caitlin E. Cox April 12, 2024
News Conference News EHRA 2024 EHRA, Others Update Consensus on Catheter and Surgical Ablation of AF Todd Neale April 08, 2024
News Daily News First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease Michael O'Riordan March 20, 2024
News Daily News FDA Approves Aprocitentan for Inadequately Controlled Hypertension Michael O'Riordan March 20, 2024